# Major Recall Alert: CYCLODX Recalled Due to Production Out-of-Specification Issue for Fludeoxyglucose 18F
The Canadian health authorities have issued a recall for the product **CYCLODX**, citing a serious deviation from manufacturing specifications. The issue stems from the **target irradiation time for the production of the active ingredient Fludeoxyglucose 18F**, which has been found to be out of compliance for the affected lot. This recall serves as a crucial reminder to always stay informed about product safety updates to protect your health.
For official details on this recall, you can visit the Government of Canada’s recall page: [CYCLODX Out of Specification Recall Notice](https://recalls-rappels.canada.ca/en/alert-recall/cyclodx-out-specification-test-results).
---
## Why This Recall is Important
Fludeoxyglucose 18F, a radioactive tracer commonly used in medical imaging tests such as PET scans, requires stringent manufacturing controls to ensure safety and efficacy. The **out-of-specification target irradiation time** raises concerns about the quality of the product, which could potentially compromise diagnostic accuracy or lead to unintended adverse effects on patient health.
For anyone relying on the precision and reliability of medical imaging, the manufacturing quality of drugs like CYCLODX is critical to ensure thorough diagnoses and safe medical procedures. This proactive recall aims to prevent potential risks posed by the impacted batch.
---
### Details of the Recall
Here are the key details about the **CYCLODX recall** you need to know:
- **Category**: Medical Product, Canada
- **Brand**: CYCLODX
- **Product**: CYCLODX (contains Fludeoxyglucose 18F)
- **Recall Reason**: The target irradiation time for Fludeoxyglucose 18F is out of specification in the affected lot.
- **Safety Measures**: Discontinue use of the affected lot immediately and contact the appropriate healthcare provider for guidance.
- **Date Announced**: October 2023
Healthcare providers and facilities using CYCLODX are specifically urged to halt administration from the affected lot and ensure the product is returned to the manufacturer per the recall guidelines.
---
### What You Should Do
If you or your healthcare provider is using **CYCLODX**, here are some immediate actions to take:
- **Check the Lot Number**: If you or your facility uses CYCLODX, confirm whether your supply comes from the affected lot. Contact the manufacturer or distributor for this information if needed.
- **Stop Usage**: Discontinue using the product from the recalled batch until further notice.
- **Consult Your Healthcare Provider**: If you’re a patient who has undergone a diagnostic test involving Fludeoxyglucose 18F recently, consult your doctor to determine if additional steps or follow-up tests are necessary.
- **Contact Authorities**: Healthcare providers should notify health authorities for specific instructions on managing unused or affected supplies.
Always prioritize your safety and contact the product’s customer service line or distributor with any remaining questions.
---
### Stay Safe – Get Instant Recall Alerts
Recalls like this emphasize the importance of staying informed about the safety of the products in your daily life. To get instant alerts about recalls in Canada, download a trusted recall app today and sign up for notifications specific to your product categories of interest.
#### Don’t wait for critical news to reach you too late – stay proactive. Download our app now to receive instant notifications on all product recalls, including health, food, and consumer goods.
---
**Stay Informed and Safe:** For the latest information on this recall, visit the [official recall page](https://recalls-rappels.canada.ca/en/alert-recall/cyclodx-out-specification-test-results). Protect your health and share this information to keep others safe!